TrialNature communications2026
Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study.
Philip L Molyneaux et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
TrialNature communications2026
Philip L Molyneaux et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.